American Journal of Infection Control

In spite of decades of effort, contaminated environmental surfaces within patient rooms remain a significant cause of healthcare associated infections. In the New York City area, the persistence of Clostridioides difficile and emergence of Candida

Over the last fifteen years, the US health care system and its patients have paid an increasingly high price for adverse events. The health care system needs safe and reliable delivery systems to prevent common causes of patient harm.1-4 Health care

Escherichia coli sequence type (ST) ST131 has emerged globally over the past two decades as a leading cause of extraintestinal E. coli infections.1,2 ST131 is closely associated with resistance to fluoroquinolones and third-generation cephalosporins

Surgical site infections (SSI) are the third most common cause of nosocomial infection in Canada and are associated with significant morbidity and mortality.1 Several studies have demonstrated that surgical antibiotic prophylaxis (SAP) reduces the

Health care-associated infections (HAIs) are the most frequent adverse events occurring during patient care and are estimated to cost a 200-bed facility more than $1.7 million per year.1-4 Inadequate hand hygiene (HH) leads to cross-transmission of

Few researchers have investigated the incidence of and risk factors for hospital-acquired pneumonia (HAP) among inpatients with mental disorders in a general hospital.

Rapidly growing mycobacteria (RGM) comprise a subset of the non-tuberculosis mycobacteria that usually grow within 7 days of subculture into solid media. They are widely distributed in the environment and able to survive extreme temperature and

Non-ventilator hospital-acquired pneumonia is associated with substantial morbidity, mortality and costs during an episode of acute care. We examined NVHAP incidence, mortality, and costs of Medicaid beneficiaries over a 5-year period (2015-2019)

Preventing healthcare-associated infection (HAI) poses a challenge to many hospitals globally.1, 2 The World Health Organization (WHO) and others have developed initiatives to promote patient safety and infection control, including guidelines from

Central line-associated bloodstream infections (CLABSI) in ambulatory pediatric populations are difficult to track at an institutional level, especially for complex patients seen by multiple clinical divisions and home health infusion agencies